Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulants and Bleeding Disorders”

228 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 228 results

Not applicableStudy completedNCT06906861
What this trial is testing

Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

Who this might be right for
Epistaxis
Institute of medicine, Maharagjung medical campus 284
Not applicableUnknownNCT00182117
What this trial is testing

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Who this might be right for
BleedingEnd Stage Renal Disease
Hamilton Health Sciences Corporation 490
Not applicableUnknownNCT04291287
What this trial is testing

Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)

Who this might be right for
Atrial FibrillationMyocardial InfarctionAnticoagulant-induced Bleeding+1 more
Scientific Institute San Raffaele 1,500
Not applicableWithdrawnNCT04808934
What this trial is testing

NOAC Portuguese Real World Study

Who this might be right for
StrokeSystemic EmbolismMajor Bleeding
Pfizer
Not applicableStudy completedNCT05224388
What this trial is testing

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Who this might be right for
COVID-19Deep Vein ThrombosisAnticoagulants and Bleeding Disorders+1 more
University Hospital, Ghent 813
Not applicableStudy completedNCT02533960
What this trial is testing

Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime

Who this might be right for
Ischemic StrokeIntracerebral HemorrhageOral Anticoagulation+2 more
University Hospital Heidelberg 3,832
Not applicableUnknownNCT03785080
What this trial is testing

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients

Who this might be right for
Upper Gastrointestinal Bleeding
Chinese University of Hong Kong 552
Not applicableStudy completedNCT04412304
What this trial is testing

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Who this might be right for
Covid-19Thromboembolic EventsBleeding
Karolinska Institutet 166
Not applicableUnknownNCT05079295
What this trial is testing

Management of Anticoagulants and Antithrombotics in Patients With CSDH

Who this might be right for
Chronic Subdural HematomaAnticoagulant-induced BleedingThromboembolic Stroke+1 more
University Hospital of Ferrara 400
Not applicableStudy completedNCT03803579
What this trial is testing

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)

Who this might be right for
Atrial FibrillationAnticoagulant-induced Bleeding
Arianna Anticoagulazione Foundation 2,000
Not applicableUnknownNCT04878497
What this trial is testing

Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

Who this might be right for
Atrial FibrillationFrailtyAnticoagulant-induced Bleeding+1 more
Brigham and Women's Hospital 1,000,000
Testing effectiveness (Phase 2)Study completedNCT03772613
What this trial is testing

The Randomized OPTIMAL-ACT Trial

Who this might be right for
Coronary Artery DiseaseIschemic Heart DiseaseAnticoagulant-induced Bleeding+1 more
Mayo Clinic 180
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726
What this trial is testing

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Les Laboratoires des Médicaments Stériles 120
Large-scale testing (Phase 3)Study completedNCT05515120
What this trial is testing

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Who this might be right for
Venous ThromboembolismAnticoagulant-induced BleedingVenous Thromboses+1 more
Instituto Mexicano del Seguro Social 58
Post-approval studies (Phase 4)Study completedNCT01452568
What this trial is testing

Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin

Who this might be right for
ThromboembolismBleeding
Rigshospitalet, Denmark 370
Not applicableUnknownNCT06232278
What this trial is testing

Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)

Who this might be right for
Atrial FibrillationCardioembolic StrokeLeft Atrial Appendage Thrombosis+1 more
University Hospital, Brest 120
Not applicableStudy completedNCT04305821
What this trial is testing

Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics

Who this might be right for
Mild Head InjuryAnticoagulantAntiplatelet
Rennes University Hospital 260
Post-approval studies (Phase 4)Enrolling By InvitationNCT03244020
What this trial is testing

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Who this might be right for
SarcomaSoft Tissue SarcomaBone Sarcoma+4 more
Massachusetts General Hospital 2,868
Not applicableUnknownNCT06543927
What this trial is testing

Frequency and Risk Factors of Bleeding in Patients With Chronic Kidney Disease Receiving Anticoagulants

Who this might be right for
Chronic Kidney Diseases Receiving Anticoagulants
Sohag University 60
Not applicableStudy completedNCT05546957
What this trial is testing

Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants

Who this might be right for
Healthy Volunteer
Regeneron Pharmaceuticals 60
Next Page